These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 7622805)

  • 1. SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients.
    Filteau MJ; Baruch P; Lapierre YD; Bakish D; Blanchard A
    Int Clin Psychopharmacol; 1995 Mar; 10(1):51-4. PubMed ID: 7622805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
    Berk M
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute tryptophan depletion in depressed patients treated with a selective serotonin-noradrenalin reuptake inhibitor: augmentation of antidepressant response?
    Booij L; Van der Does AJ; Haffmans PM; Riedel WJ
    J Affect Disord; 2005 Jun; 86(2-3):305-11. PubMed ID: 15935252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
    Rabasseda X
    Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
    Papakostas GI; Stahl SM; Krishen A; Seifert CA; Tucker VL; Goodale EP; Fava M
    J Clin Psychiatry; 2008 Aug; 69(8):1287-92. PubMed ID: 18605812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
    Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
    Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
    Frazer A
    J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.
    McCabe C; Mishor Z; Cowen PJ; Harmer CJ
    Biol Psychiatry; 2010 Mar; 67(5):439-45. PubMed ID: 20034615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 13. Are SSRIs really more effective for anxious depression?
    Panzer MJ
    Ann Clin Psychiatry; 2005; 17(1):23-9. PubMed ID: 15941028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients.
    Filteau MJ; Lapierre YD; Bakish D; Blanchard A
    J Psychiatry Neurosci; 1993 May; 18(3):114-9. PubMed ID: 8499427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A; Bosc M; Polin V
    J Psychopharmacol; 1997; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM; Entsuah R; Rudolph RL
    Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J
    J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.
    Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC
    Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.